Key Points
- Axon Enterprise director Caitlin Elizabeth Kalinowski sold 564 shares on June 1 at an average price of $478.97, totaling about $270,139. After the sale, she still held 3,632 shares, a 13.44% reduction in her position.
- Axon stock was trading higher, opening at $490.12 and up 2.8% on the session, with the company carrying a market cap of about $39.5 billion.
- Recent earnings topped expectations, as Axon reported $1.61 EPS versus the $1.60 estimate and revenue of $807.35 million, up 33.7% year over year. Analysts remain generally bullish, with a consensus rating of “Moderate Buy” and an average price target of $712.75.
Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) Director Caitlin Elizabeth Kalinowski sold 564 shares of Axon Enterprise stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $478.97, for a total value of $270,139.08. Following the completion of the transaction, the director directly owned 3,632 shares in the company, valued at $1,739,619.04. This represents a 13.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Axon Enterprise Trading Up 2.8%
NASDAQ:AXON opened at $490.12 on Wednesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.27 and a quick ratio of 1.93. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91. The stock's 50-day moving average is $407.02 and its two-hundred day moving average is $493.35. The stock has a market cap of $39.50 billion, a PE ratio of 196.84, a price-to-earnings-growth ratio of 8.67 and a beta of 1.45.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company had revenue of $807.35 million for the quarter, compared to analysts' expectations of $778.91 million. During the same quarter in the previous year, the business posted $1.47 EPS. The business's revenue for the quarter was up 33.7% on a year-over-year basis. As a group, equities research analysts forecast that Axon Enterprise, Inc will post 1.82 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have weighed in on the company. Wall Street Zen raised Axon Enterprise from a "sell" rating to a "hold" rating in a research note on Saturday, February 28th. Morgan Stanley set a $600.00 target price on Axon Enterprise in a research note on Thursday, May 7th. TD Cowen lowered their target price on Axon Enterprise from $950.00 to $825.00 and set a "buy" rating on the stock in a research note on Wednesday, April 8th. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. lifted their target price on Axon Enterprise from $750.00 to $755.00 and gave the company an "overweight" rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $712.75.
View Our Latest Stock Report on AXON
Institutional Investors Weigh In On Axon Enterprise
Institutional investors have recently made changes to their positions in the company. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $28,000. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $29,000. Sound Income Strategies LLC lifted its holdings in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company's stock valued at $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $30,000. Finally, AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter valued at about $34,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
About Axon Enterprise
(
Get Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
